Comments
Commented by André Will-Laudien on March 10th, 2023 | 10:15 CET
Defeat cancer! Defence Therapeutics, BioNTech, Morphosys, Bayer - These biotechs are close
The listed biotechnology sector has entered a strong correction phase since the COVID-19 pandemic mode ended. In the process, sector leader BioNTech suffered a loss of over 70% from its high. Compounding the problem for companies is the significant increase in interest rates for long-term financing. The segment relies on revolving investor capital, but the corresponding risk parameters have been adjusted upward, making some refinancings extremely expensive. Costs are rising, which is leading to renewed price markdowns. However, some companies are convincing through their innovative strength and have recently outperformed the market. We take a closer look at the blockbuster stocks.
Read
Commented by Stefan Feulner on March 10th, 2023 | 10:08 CET
Plug Power and Nordex disappoint, and a milestone for Manuka Resources
The shift to renewable energy is being accelerated significantly by policymakers and industry, but companies continue to struggle to meet their plan targets. Nevertheless, the market outlook is optimistic that the transformation to alternative energy will continue to gain momentum. One of the cost drivers is the high cost of raw materials, which has increased significantly again due to the sanctions against Russia. Manuka Resources is still a young player in the market that could significantly cushion the shortages of the critical raw material vanadium, which is needed for energy storage systems.
Read
Commented by Juliane Zielonka on March 10th, 2023 | 10:06 CET
Tocvan Ventures, JinkoSolar, Commerzbank - With gold and silver towards a real energy turnaround
Gold and silver prices will continue to rise in 2023, as a weaker US dollar and loose monetary policy should drive precious metals higher. There is great joy at Tocvan Ventures in light of the latest drilling results. The team expects the Pilar area to produce similar results to other miners in the region. Precious metals are finding great sales in the solar industry. Investors will learn today the business results of solar panel manufacturer JinkoSolar. The Chinese company has recently been allowed to export to the US again. Commerzbank has to cope with a touch of greenwashing; a district court made a momentous judgement for a subsidiary.
Read
Commented by Nico Popp on March 9th, 2023 | 10:58 CET
Innovations for millions: Volkswagen, JinkoSolar, Meta Materials
If a company is ahead of the competition, its business runs all by itself. Large companies invest billions to set themselves apart from the market. But the structure of corporations too often puts the brakes on visionary projects. Fortunately, there are smaller companies that are wholly committed to new technology. We present three companies and explain which could soon become the focus of the big players.
Read
Commented by André Will-Laudien on March 9th, 2023 | 10:56 CET
Running out of fuel? BYD, Porsche, VW, Globex Mining - Metals in demand!
In benchmarking, anyone who sees electromobility at the forefront cannot ignore a powerful battery. In the last 3 years, there have been no real leaps forward in development, but at least power compression in lithium-ion technology achieved a doubling of the range and, in parallel, also lowered the previously long charging times. This made an electric vehicle suitable for long-distance travel for the first time, even though faster discharge must be expected in winter due to non-engine services such as heating. But technological development continues, and BYD, as one of the world market leaders, sets technological standards. Which stocks are the favourites in the sector?
Read
Commented by Juliane Zielonka on March 9th, 2023 | 10:54 CET
Aspermont, Amazon, Shop Apotheke - These shares embrace digitization!
Companies like the Canadian media company Aspermont are among the pioneers of digitization and are thus miles ahead of their competitors. With their unique platform solution, the original mining trade magazine publisher can quickly scale into other segments and keep both industry and experts up to date with the latest knowledge. The value of successful digitization is also evident in the Shop Apotheke business figures now published. The digital mail-order pharmacy, which is accessible in Europe, is able to score points despite a change in the management board. In the US, Amazon is one step further, launching 24/7 digital patient care operations through One Medical.
Read
Commented by Fabian Lorenz on March 9th, 2023 | 10:52 CET
BioNTech, Pfizer, Bayer and BioNxt Solutions on the biotech takeover merry-go-round
2023 could become the year of takeovers in the pharmaceutical and biotech sectors. This is what the experts at PwC expect. Thus, at the JP Morgan industry conference in San Francisco, not only were takeover candidates discussed but billion-dollar transactions were reported. One reason is the Inflation Reduction Act in the USA. This allows negotiations on drug prices. To prevent sales declines, Big Pharma must invest in new top sellers. And it is already doing so. The latest takeover rumor comes from BioNTech partner Pfizer. At BioNTech, the negative news currently outweighs the positive. Whether Bayer will take action with the boss or be taken over itself is not yet entirely clear. But there are also opportunities for investors in the smallcap sector. Take BioNxt Solutions, for example - the Canadian company with its operational focus in Germany recently secured new patents, and the share price has jumped.
Read
Commented by Armin Schulz on March 9th, 2023 | 10:49 CET
TUI, Saturn Oil + Gas, Plug Power - Three shares with doubling potential
Finding shares with doubling potential requires a thorough analysis. On the one hand, the company's sector should have growth potential. If the sector is innovative, that also speaks in favour of the share. Then, a look at the competitors is important to see if the company is well positioned. If both factors fit, one should take a closer look at the candidate's finances. If you can tick off several items on this checklist, it is worth taking a closer look at the chart technique. Today we look at three candidates that have what it takes to double their share prices, at least in the long term.
Read
Commented by Nico Popp on March 8th, 2023 | 16:27 CET
Banks have a problem: Commerzbank, Deutsche Bank, Desert Gold
Bank shares have done well in recent months - the turnaround in interest rates has been good for many institutions. In the meantime, more and more analysts are giving banks the thumbs up. But what if currencies like the euro or the dollar lose influence? We shed light on secret trends emanating from Asian central banks, which at least argue for not investing all funds in traditional currencies.
Read
Commented by Fabian Lorenz on March 8th, 2023 | 16:22 CET
Nel share slumps, a 60% chance with Bayer, Almonty Industries and BASF
The Nel share was one of the big daily losers yesterday. As a result, the upward trend has finally been broken, and analysts' opinions differ widely. Berenberg sees the BASF share as a hold after the publication of the quarterly figures. The price target is EUR 55. The figures are in line with expectations. However, the end of share buybacks and concerns about future competitiveness weigh on the stock. By contrast, analysts see up to 60% upside potential for Bayer. Almonty Industries is benefiting from the boom in electromobility and also defense spending. As the leading tungsten producer outside China, analysts suspect it could soon come to a bidding war.
Read